ARTICLE
16 October 2020

Health Care And COVID – Regulation, Fraud And Enforcement

AG
Akin Gump Strauss Hauer & Feld LLP

Contributor

Akin is a law firm focused on providing extraordinary client service, a rewarding environment for our diverse workforce and exceptional legal representation irrespective of ability to pay. The deep transactional, litigation, regulatory and policy experience we bring to client engagements helps us craft innovative, effective solutions and strategies.
In this episode, Akin Gump health care partners Kelly Cleary and Robert Salcido discuss the health care industry and how COVID-19
United States Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

Subscribe to  OnAir with Akin Gump via iTunes, SoundCloud, YouTube, Spotify and  Google Play.

In this episode, Akin Gump health care partners Kelly Cleary and Robert Salcido discuss the health care industry and how COVID-19 has impacted the industry and affected or driven legislative and regulatory activity.

Among the topics covered:

  • The Stark Law and conflicts of interest.
  • Oversight of the CARES Act.
  • The False Claims Act and its current and future enforcement.
  • Drug pricing models.
  • Takeaways for business.

To learn more, visit our Health Care and Life Sciences page on akingump.com

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More